Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2015
10 March 2016 - 11:46AM
Enzymotec Ltd. (NASDAQ:ENZY) (“Company”), a developer, manufacturer
and marketer of innovative bio-active lipid-based nutritional
ingredients and medical foods, announced today that it has filed
its annual report on Form 20-F for the fiscal year ended December
31, 2015 with the U.S. Securities and Exchange Commission (“SEC”).
The annual report on Form 20-F, which contains audited financial
statements, can be accessed on the SEC’s website at
http://www.sec.gov/ as well as via the Company’s investor relations
website at http://ir.enzymotec.com/.
The Company will also deliver a hard copy of its
annual report on Form 20-F, including its complete audited
financial statements, free of charge, to its shareholders upon
request to Oren Bryan at ir@enzymotec.com.
About Enzymotec Ltd.Enzymotec
is a leading global supplier of specialty lipid-based products and
solutions. The Company develops, manufactures, and markets
innovative bio-active lipid based nutritional ingredients and
medical foods, driven by a deep core of cutting-edge, proprietary
technologies intended to improve people’s health. For more
information, visit www.enzymotec.com.
Company Contact:
Enzymotec Ltd.
Oren Bryan
Chief Financial Officer
Phone: +972747177177
ir@enzymotec.com
Investor Relations Contact:
The Ruth Group
Tram Bui / Lee Roth
Phone: 646-536-7035 / 7012
tbui@theruthgroup.com
lroth@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles